
Vir Biotechnology CEO Discusses Cancer Pipeline as Biotech M&A Heats Up
Vir Biotechnology’s chief executive outlined progress on the company’s experimental cancer treatment while addressing potential deal activity, as the clinical-stage biotech navigates a sector seeing..





